Literature DB >> 11115267

Immunophenotypic shift in a case of mycosis fungoides with vitreous invasion.

N Lois1, P S Hiscott, J Nash, D Wong.   

Abstract

The case of an 82-year-old man who developed intraocular extension from mycosis fungoides, a cutaneous T-cell lymphoma, is presented. The patient died soon after intraocular involvement occurred. Immunohistochemistry of a skin biopsy, taken early in the course of the disease, disclosed a predominance of T cells with a helper/inducer phenotype (CD4(+)). However, an intraocular infiltrate obtained 7 years later contained mostly T cells with a suppressor/cytotoxic phenotype (CD8(+)). The occurrence of ocular invasion, the change in immunophenotype, and the predominant proliferation of CD8(+) lymphocytes may have been related to the poor outcome in this patient.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11115267     DOI: 10.1001/archopht.118.12.1692

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  4 in total

1.  Intraocular involvement of mycosis fungoides associated with immunophenotypic switch from CD4+ to CD8<sup/>.

Authors:  Jonathan A Braue; Anthony B Daniels; Jeffrey P Zwerner; Stephen J Kim; John A Zic
Journal:  Blood       Date:  2018-01-03       Impact factor: 22.113

Review 2.  Primary intraocular lymphoma of T-cell type: report of a case and review of the literature.

Authors:  Sarah E Coupland; Gerasimos Anastassiou; Norbert Bornfeld; Michael Hummel; Harald Stein
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-12-10       Impact factor: 3.117

Review 3.  Primary intraocular lymphoma: a review of the clinical, histopathological and molecular biological features.

Authors:  Sarah E Coupland; Heinrich Heimann; Nikolaos E Bechrakis
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-10-29       Impact factor: 3.117

4.  Ophthalmic manifestations, cytology, immunohistochemistry, and molecular analysis of intraocular metastatic T-cell lymphoma: report of a case and review of the literature.

Authors:  Grace A Levy-Clarke; David Greenman; Pamela C Sieving; Gordon Byrnes; Defen Shen; Robert Nussenblatt; Chi-Chao Chan
Journal:  Surv Ophthalmol       Date:  2008 May-Jun       Impact factor: 6.048

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.